大港股份(002077.SZ):上半年淨利預增144.68%-207.42%
格隆匯7月12日丨大港股份(002077.SZ)披露2021年半年度業績預吿,公司預計上半年歸屬於上市公司股東的淨利潤7800萬元–9800萬元,比上年同期增長144.68%-207.42%。基本每股收益0.1344元/股–0.1689元/股。
2020年7月,公司完成了資產置換,以應收款項置換金港租賃30%股權和金控租賃30%股權。報吿期確認兩家參股公司投資收益對公司上半年利潤影響約2500萬元-3000萬元。
報吿期內,公司所持有的天奈科技股票公允價值變動及減持天奈科技股票獲取的收益對上半年利潤的影響約為5000萬元-5800萬元,為非經常性損益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.